Optikira LLC;The Regents of the University of California
发明人:
申请号：
EP18849820.8
公开号：
EP3675858A2
申请日:
2018.08.31
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides novel compounds, compositions and methods for treating or preventing an IRE1α-related disease or disorder. In certain embodiments, the disease or disorder is selected from the group consisting of a neurodegenerative disease, a demyelinating disease, cancer, an eye disease, a fibrotic disease, and diabetes.
